Therefore, we suggest that ESGA protects against NAFLD through its antioxidant and anti-inflammatory effects, mediated by the activation of Nrf2 and suppression of NF-κB. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.